Publicacións nas que colabora con José Alberto Miranda Filloy (18)

2019

  1. Long-term survival of subcutaneous anti-tumor necrosis factor biological drugs administered between 2008 and 2012 in a cohort of rheumatoid arthritis patients

    Reumatologia Clinica, Vol. 15, Núm. 1, pp. 54-57

2013

  1. Biopsy-proven giant cell arteritis patients with coronary artery disease have increased risk of aortic aneurysmal disease and arterial thrombosis

    Clinical and Experimental Rheumatology

2012

  1. Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy

    Mediators of Inflammation, Vol. 2012

2009

  1. Paniculitis: concepto, clasificación, manifestaciones clínicas y diagnóstico

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 10, Núm. 33, pp. 2199-2204

  2. Panniculitis: Concept, classification, clinical manifestations and diagnosis

    Medicine, Vol. 10, Núm. 33, pp. 2199-2204

2008

  1. Reply

    Clinical and Experimental Rheumatology

2007

  1. Chapter 13 Henoch-Schönlein Purpura

    Handbook of Systemic Autoimmune Diseases, Vol. 7, pp. 241-255

  2. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors

    Arthritis Care and Research, Vol. 57, Núm. 2, pp. 287-293

  3. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis

    Arthritis Care and Research, Vol. 57, Núm. 1, pp. 125-132

  4. Lack of association between interleukin-6 promoter polymorphism at position -174 and Henoch-Schönlein purpura

    Clinical and Experimental Rheumatology, Vol. 25, Núm. 1 SUPPL. 44

2006

  1. Cardiovascular disease in rheumatoid arthritis

    Biomedicine and Pharmacotherapy, Vol. 60, Núm. 10, pp. 673-677

  2. Eritema nudoso

    Jano: Medicina y humanidades, Núm. 1593, pp. 31

  3. Giant cell arteritis and polymyalgia rheumatica: Pathophysiology and management

    Drugs and Aging, Vol. 23, Núm. 8, pp. 627-649

  4. Giant cell arteritis: Diagnosis and therapeutic management

    Current Rheumatology Reports, Vol. 8, Núm. 4, pp. 299-302

  5. Lack of Echocardiographic and Doppler Abnormalities in Psoriatic Arthritis Patients Without Clinically Evident Cardiovascular Disease or Classic Atherosclerosis Risk Factors

    Seminars in Arthritis and Rheumatism, Vol. 35, Núm. 5, pp. 333-339

  6. Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis

    Clinical and Experimental Rheumatology, Vol. 24, Núm. 5, pp. 576-579

  7. Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in Northwest Spain

    Journal of Rheumatology, Vol. 33, Núm. 2, pp. 285-288

  8. Microscopic polyangiitis following recurrent Staphylococcus aureus bacteremia and infectious endocarditis

    Clinical and Experimental Rheumatology, Vol. 24, Núm. 6, pp. 705-706